These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15352159)

  • 81. Malignancy in controlled regression. A new aspect of pathology.
    Lipkin G
    Am J Dermatopathol; 1980; 2(1):75-7. PubMed ID: 7246972
    [No Abstract]   [Full Text] [Related]  

  • 82. Time reversal in biological systems.
    Glassman ML; Hochberg A
    Med Hypotheses; 1997 Dec; 49(6):505-8. PubMed ID: 9466374
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Altered growth pattern, not altered growth per se, is the hallmark of early lesions preceding cancer development.
    Doratiotto S; Marongiu F; Faedda S; Pani P; Laconi E
    Histol Histopathol; 2009 Jan; 24(1):101-6. PubMed ID: 19012249
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Cancer models, genomic instability and somatic cellular Darwinian evolution.
    Little MP
    Biol Direct; 2010 Apr; 5():19; discussion 19. PubMed ID: 20406436
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A theory of cellular-function pathology: further development of Virchow's theory of cellular pathology.
    Yabrov A
    Med Hypotheses; 2001 Apr; 56(4):434-41. PubMed ID: 11339843
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Multifocality and recurrence risk: a quantitative model of field cancerization.
    Foo J; Leder K; Ryser MD
    J Theor Biol; 2014 Aug; 355():170-84. PubMed ID: 24735903
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The Systemic-Evolutionary Theory of the Origin of Cancer (SETOC): A New Interpretative Model of Cancer as a Complex Biological System.
    Mazzocca A
    Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31581628
    [TBL] [Abstract][Full Text] [Related]  

  • 88. What history tells us XXVIII. What is really new in the current evolutionary theory of cancer?
    Morange M
    J Biosci; 2012 Sep; 37(4):609-12. PubMed ID: 22922186
    [No Abstract]   [Full Text] [Related]  

  • 89. Mutation or not, what directly establishes a neoplastic state, namely cellular immortality and autonomy, still remains unknown and should be prioritized in our research.
    Zhu S; Wang J; Zellmer L; Xu N; Liu M; Hu Y; Ma H; Deng F; Yang W; Liao DJ
    J Cancer; 2022; 13(9):2810-2843. PubMed ID: 35912015
    [TBL] [Abstract][Full Text] [Related]  

  • 90. 27th Maude Abbott lecture. Cancer development as viewed by a pathologist: a different perspective.
    Farber E
    Mod Pathol; 1988 Jan; 1(1):2-3. PubMed ID: 3237688
    [No Abstract]   [Full Text] [Related]  

  • 91. Life is determined by its environment.
    Torday JS; Miller WB
    Int J Astrobiol; 2016 Oct; 15(4):345-350. PubMed ID: 27708547
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Applying ecological and evolutionary theory to cancer: a long and winding road.
    Thomas F; Fisher D; Fort P; Marie JP; Daoust S; Roche B; Grunau C; Cosseau C; Mitta G; Baghdiguian S; Rousset F; Lassus P; Assenat E; Grégoire D; Missé D; Lorz A; Billy F; Vainchenker W; Delhommeau F; Koscielny S; Itzykson R; Tang R; Fava F; Ballesta A; Lepoutre T; Krasinska L; Dulic V; Raynaud P; Blache P; Quittau-Prevostel C; Vignal E; Trauchessec H; Perthame B; Clairambault J; Volpert V; Solary E; Hibner U; Hochberg ME
    Evol Appl; 2013 Jan; 6(1):1-10. PubMed ID: 23397042
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Models of carcinogenesis: an overview.
    Vineis P; Schatzkin A; Potter JD
    Carcinogenesis; 2010 Oct; 31(10):1703-9. PubMed ID: 20430846
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Genetic and Non-Genetic Mechanisms Underlying Cancer Evolution.
    Shlyakhtina Y; Moran KL; Portal MM
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33803675
    [TBL] [Abstract][Full Text] [Related]  

  • 95. A systematic approach to cancer: evolution beyond selection.
    Miller WB; Torday JS
    Clin Transl Med; 2017 Dec; 6(1):2. PubMed ID: 28050778
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Preventive evolutionary medicine of cancers.
    Hochberg ME; Thomas F; Assenat E; Hibner U
    Evol Appl; 2013 Jan; 6(1):134-43. PubMed ID: 23396860
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A response to "Concepts in malignant transformation" - a pathologists perspective.
    Morse N
    S Afr J Surg; 2015 Dec; 53(3 and 4):5-7. PubMed ID: 28240473
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Changes in capillary resistance in cancer patients as a function of the malignancy of the tumor].
    LACHAPELE AP; BRUE F; BABIN R
    Bull Assoc Fr Etud Cancer; 1957; 44(3):444-7. PubMed ID: 13510910
    [No Abstract]   [Full Text] [Related]  

  • 99. Criteria of malignancy. II. Biological consideration of normal and abnormal cell lines.
    MOORE AE
    Trans N Y Acad Sci; 1957 Mar; 19(5):435-46. PubMed ID: 13422561
    [No Abstract]   [Full Text] [Related]  

  • 100. Criteria of malignancy. I. Morphology of Detroit strains of human cells in tissue culture.
    BERMAN L; STULBERG CS; RUDDLE FH
    Trans N Y Acad Sci; 1957 Mar; 19(5):432-4. PubMed ID: 13422560
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.